首页> 外文期刊>Journal of Holistic Nursing and Midwifery >Incidence and Extent of Bruising After Subcutaneous Injection of Enoxaparin Sodium in Patients Hospitalized at Coronary Care Units
【24h】

Incidence and Extent of Bruising After Subcutaneous Injection of Enoxaparin Sodium in Patients Hospitalized at Coronary Care Units

机译:冠心病科住院患者皮下注射依诺肝素钠后瘀伤的发生率和程度

获取原文
       

摘要

Introduction: Bruising or ecchymosis after subcutaneous injection of enoxaparin sodium can cause anxiety and discomfort in the patient. Therefore, nurses should know the factors associated with the incidence and extent of this complication.Objective: This study aims to investigate incidence and extent of bruising after subcutaneous injection of enoxaparin sodium and its related factors in patients hospitalized at coronary care unit of Dr. Heshmat educational and treatment center in Rasht City, Iran.Materials and Methods: This analytical cross-sectional study was conducted on 84 patients hospitalized at coronary care unit in 2015. They were under treatment with enoxaparin sodium 6000 IU. The samples were selected using consecutive sampling method. To standardize the injection method, all injections were performed by one nurse as the member of research team at the right side of the abdomen and above the navel in 10 seconds (using a chronometer). Evaluation of the incidence and extent of bruising was done by a trained nurse 48 hours after the injection. The study instrument consists of demographic-clinical characteristics of the patients and records of the incidence and extent of bruising. These data were collected by interview, observation, and measurement using a flexible transparent ruler. The incidence and extent of bruising (under three categories of “insignificant bruise”, “small bruise”, and “large bruise”) were analyzed using descriptive (frequency, mean, standard deviation) and inferential (Chi-squared test, Independent t-test, and ANOVA) statistics.Results: The majority of the study samples were women (65.5%) with a mean age of 66±11 years. Bruising was seen in 53.6% of samples of which 56% of them had insignificant bruising, 23% small bruises, and 21% large bruises. The incidence of bruising had significant relationship with hyperlipidemia (P=0.028) and the extent of bruising was significantly correlated with hypertension (P=0.048).Conclusion: Based on the results, we should consider and screen hyperlipidemia and hypertension in the patients with heart problems treated with enoxaparin sodium with respect to the incidence and extent of bruising.
机译:简介:皮下注射依诺肝素钠后出现瘀伤或瘀斑会引起患者焦虑和不适。因此,护士应了解与这一并发症的发生率和程度有关的因素。目的:本研究旨在调查在赫什马特医生的冠心病监护病房住院的患者皮下注射依诺肝素钠后瘀伤的发生率,程度及其相关因素。材料与方法:这项分析性横断面研究于2015年对84例在冠心病监护病房住院的患者进行。他们接受依诺肝素钠6000 IU的治疗。使用连续采样方法选择样本。为了使注射方法标准化,所有注射均由一名护士作为研究团队的一员在腹部右侧和肚脐上方进行,时间为10秒(使用计时器)。注射后48小时,由训练有素的护士评估瘀伤的发生率和程度。该研究仪器包括患者的人口统计学特征以及瘀伤的发生率和程度的记录。这些数据是使用灵活的透明标尺通过访谈,观察和测量收集的。使用描述性(频率,均值,标准差)和推论性(卡方检验,独立t检验)分析了瘀伤的发生率和程度(分为“轻度瘀伤”,“小瘀伤”和“大瘀伤”三类)。结果:大多数研究样本是女性(65.5%),平均年龄为66±11岁。在53.6%的样本中发现瘀伤,其中56%的瘀伤微不足道,其中23%的是小瘀伤,而21%的是大瘀伤。瘀伤的发生与高脂血症有显着相关性(P = 0.028),瘀伤的程度与高血压有显着相关性(P = 0.048)。结论:根据研究结果,我们应该考虑和筛查心脏病患者的高脂血症和高血压用依诺肝素钠治疗瘀伤的发生率和程度方面的问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号